Umbilical Cord Blood (UCB) Stem Cell Market size worth $ 12.06 Billion, Globally, by 2028 at 16.68% CAGR: Verified Market Research®

Umbilical cord blood stem cells have the potential to treat chronic diseases and some rare diseases effectively, huge investment from market players to develop cost effective treatment are the crucial factors driving the growth of the market

JERSEY CITY, N.J., March 29, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Umbilical Cord Blood (UCB) Stem Cell Market" By Product Type (Stem Cell Transplant, Autologous Transplant, Allogenic Transplant), By Distribution Channel (Therapeutics Service Companies, Private and Government Research Institutes), and By Geography. According to Verified Market Research, the Global Umbilical Cord Blood (UCB) Stem Cell Market size was valued at USD 3.52 Billion in 2020 and is projected to reach USD 12.06 Billion by 2028, growing at a CAGR of 16.68% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=61914

Browse in-depth TOC on "Umbilical Cord Blood (UCB) Stem Cell Market"

202 - Pages

126 – Tables

37 – Figures

Global Umbilical Cord Blood (UCB) Stem Cell Market Overview

The approaches of cord blood stem cells are rising at a faster pace than other stem cell techniques due to its efficient and cost-effective treatment process. Umbilical cord blood (UCB) is rich in hematopoietic stem cells (HSCs) and is an attractive alternative to harvesting HSCs from bone marrow or when mobilized into the peripheral blood. One of the most appealing attributes of UCB is that it can be banked for future use and hence provides an off-the-shelf solution for patients in urgent need of a transplantation A momentous increase in chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease, etc. has increased the need for a cost-effective and efficient way of treatment.

However, umbilical cord blood stem cells have the potential to treat these chronic diseases effectively is the crucial factor driving the growth of the Umbilical Cord Blood (UCB) Stem Cell Market. Besides, the lab values for white blood cell and platelet production take a longer time to increase after umbilical cord blood stem cell transplants as compared to bone marrow stem cell transplants. It is anticipated that this factor may hamper the growth of the market. The charge of stem cell treatment has a significant impact on the growth of the market in developed countries.

Key Developments

• In January 2022, Pluristem Therapeutics a leading biotechnology company announced the launch of an innovative collaboration with Tnuva Group ("Tnuva Group" or "Tnuva"), Israel's largest food producer, (together, "Parties") to develop, manufacture and commercialize cultured cell-based products for the food industry.
• In April 2019, Osiris Therapeutics, Inc. Announces the Closing of Acquisition by Smith & Nephew plc through the consummation of a merger of Osiris with and into an indirect wholly-owned subsidiary of Smith & Nephew (the "Subsidiary").

Key Players

The major players in the market are Cytori Therapeutics, Mesoblast, NeoStem, Opexa Therapeutics, Caladrius Biosciences, Osiris Therapeutics, Pluristem Therapeutics, Advanced Cell Technology, Athersys and California Stem Cell among others.

Verified Market Research has segmented the Global Umbilical Cord Blood (UCB) Stem Cell Market On the basis of Product Type, Distribution Channel, and Geography.

• Industrial Robotic Motors Market, By Product Type
• Stem Cell Transplant
• Autologous Transplant
• Allogenic Transplant
• Transplant Medicine
• Regenerative Medicine
• Others
• Industrial Robotic Motors Market, By Distribution Channel
• Therapeutics Service Companies
• Private and Government Research Institutes
• Academic Institutes
• Research-Based Pharmaceutical Companies
• Public and Private Cord Blood Banks
• Others
• Umbilical Cord Blood (UCB) Stem Cell Market by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Regenerative Medicine Market By Therapy (Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based Products and Acellular Products), By Application (Central Nervous System Diseases, Oncology, Diabetes), By Geography, Forecast, 2021-2028

Intraoperative Radiation Therapy Market By Technology (Electron IORT & Intraoperative Brachytherapy), By Product and Service (Products, Systems/Accelerators, Applicators & Afterloaders, Treatment Planning Systems, Accessories, & Services), By Application (Breast Cancer, Brain Tumor, & Lung Cancer), By Geography, Forecast, 2021-2028

Central Nervous System Therapeutics Market By Disease (Neurovascular Diseases, Trauma, Mental Health), By Drug Class (Analgesics, Nervous System Drugs, Anesthetics), By Geography, Forecast, 2021-2028

Immunohistochemistry (IHC) Market By Product (Antibodies, Reagents, Equipment), By Application (Diagnostic, Research, and Forensic), By End User (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Geography, Forecast, 2021-2028

Top 7 Cell Culture Companies helping scientific community by growing cells in artificial environment

Visualize Umbilical Cord Blood (UCB) Stem Cell Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]  
Web: https://www.verifiedmarketresearch.com/  
Follow Us: LinkedIn | Twitter

SOURCE Verified Market Research